acridines has been researched along with Local Neoplasm Recurrence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SEYDEL, HG | 1 |
| Alvarez, RD; Barnes, MN; Cohn, D; Estes, JM; Leath, CA; Modiano, MR; Sawyer, M; Straughn, JM; Williams, S | 1 |
| Balasubramaniam, S; Baron, AT; Boardman, CH; Lafky, JM; Maihle, NJ; Podratz, KC; Suman, VJ | 1 |
| Blessing, JA; Bookman, MA; Creasman, WT; Plaxe, SC | 1 |
| Blessing, JA; Dunton, CJ; Husseinzadeh, N; Plaxe, SC; Rader, JS; Webster, KD | 1 |
| Cook, RW; Gale, RE; Harvey, RC; Langabeer, SE; Linch, DC; Mackinnon, S | 1 |
| Campone, M; Coudert, B; de Balincourt, C; de Jonge, M; Dittrich, C; Fumoleau, P; Lacombe, D; Rampling, R; Sorio, R; Twelves, C; Van den Bent, M | 1 |
4 trial(s) available for acridines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer.
Topics: Acridines; Adult; Aged; Antineoplastic Agents; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Pyrazoles | 2006 |
Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
Topics: Acridines; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Pyrazoles | 2002 |
Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Topics: Acridines; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pyrazoles | 2002 |
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme.
Topics: Acridines; Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2002 |
3 other study(ies) available for acridines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
RADIATION-INDUCED CHANGES IN THE CYTOPLASMIC ACRIDINE ORANGE STAINING OF EXFOLIATED CELLS.
Topics: Acridine Orange; Acridines; Cytodiagnosis; Cytoplasm; Female; Fluorescent Dyes; Humans; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Radiotherapy Dosage; RNA; RNA, Neoplasm; Staining and Labeling; Uterine Neoplasms; Vaginal Smears | 1965 |
Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Topics: Acridines; Adult; Aged; Biomarkers, Tumor; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Disease Progression; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunosorbent Techniques; Laparotomy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Mas; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tumor Cells, Cultured | 1999 |
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia.
Topics: Acridines; Bone Marrow Transplantation; DNA Probes; Fusion Proteins, bcr-abl; Gene Amplification; Graft Enhancement, Immunologic; Humans; Hybridization, Genetic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Risk Factors; RNA, Messenger; RNA, Neoplasm; Succinimides; Transcription, Genetic | 2002 |